Biography
Richard Hobbs is the Mercian Professor of Primary Care, Head of Oxford Primary Care, and Director of the Oxford Institute of Digital Health, all at the University of Oxford. He is also a Pro-Vice-Chancellor (WP) at Oxford, and served on the University Council, its governing body, for 11 years and was a University Trustee (2012-24). He is also a director and current chair of PROXEMIS, a joint venture between the University of Oxford and EMIS, and a director of OUPD, a university joint venture with Legal and General.
He has made major contributions to growing primary care academic capacity, in terms of people development and research networks. A highly cited primary care clinician scientist, he has authored over 600 peer reviewed publications, has an h-index of 119, with >134,000 citations (136 papers with >100 citations, 20 papers >1000, and 15 papers >2000). Outstanding track record in cardiovascular disease research, delivering trials that changed international guidelines and practice, especially in the areas of heart failure burden and diagnosis (ECHOES and REFER trials), chronic kidney disease (BARACK-D RCT, OxREN), stroke prevention in atrial fibrillation (BAFTA, SAFE, and SMART trials), and hypertension self-management (TASMINH 1-5). He also leads a new Institute of Applied Digital Science at Oxford, with 8 globally impactful PIs and their multi-disciplinary teams covering real-time disease surveillance, cohort linkage studies, validated risk scores and clinical decision rules, pharmaco-epidemiology, digitally-enabled patient self-management, practice performance dashboards and prescribing e-interventions, and a novel pragmatic digital trial platform (ORCHID). At the onset of COVID-19 he re-tasked much of his research to urgent COVID studies and is PI or co-PI of all the main UK National Urgent Public Health Priority Studies in primary care, including the national repurposed therapies platform trial (PRINCIPLE), national COVID & Flu Surveillance for HSE (ORCHID), the national PC diagnostics platform trial (RAPTOR/CONDOR), and the national COVID novel anti-viral platform trial ({PANORAMIC).
Richard has served on many national and international scientific and research funding boards in UK, Ireland, Canada, and WHO, including the BHF Council, British Primary Care Cardiovascular Society, and the ESC Council for Cardiovascular Primary Care. He currently chairs the European and International Primary Care Cardiovascular Societies, a WONCA Special Interest Group. He was the National Director, NIHR School for Primary Care Research (2008-2021) and National Director, NHS Quality and Outcomes Framework (QOF) Review Panel (2005-09).
He was the fifth recipient of the RCGP Discovery Prize in 2018 (occasional awards since 1953), received an inaugural Distinguished Researcher Shine Prize and Best Oral Presentation Prize at WONCA World Congress in 2018, and was awarded a CBE for services to medical research in the 2019 New Year’s Honours List.